Filing Flows › Regenerative Medical Technology Group (RMTG) › Capital expenditures
Regenerative Medical Technology Group (RMTG) capital expenditures by quarter
Regenerative Medical Technology Group's capital expenditures were $43K in Q2 2026 (second quarter 2026), -86% from Q1 2026. Over the last 4 quarters it ranged from $43K (Q2 2026) to $315K (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $43K | -86% | — |
| Q1 2026 | $315K | +18% | — |
| Q4 2025 | $267K | +434% | +434% |
| Q4 2024 | $50K | — | — |
Q2 2026 at a glance
Regenerative Medical Technology Group, Q2 2026: revenue $4.0M (+309% year over year), operating margin 14.1%, net loss $2.9M, operating cash flow $332K. The chart follows the revenue to costs, profit and cash.
Questions
What is Regenerative Medical Technology Group's capital expenditures?
Regenerative Medical Technology Group's capital expenditures were $43K in Q2 2026 (second quarter 2026), -86% from Q1 2026.
How has Regenerative Medical Technology Group's capital expenditures changed?
Over the last 4 quarters it ranged from $43K (Q2 2026) to $315K (Q1 2026).
Q2 2026 results → · How Regenerative Medical Technology Group makes money →